Article
Liver enzyme elevation in hepatitis C virus (HCV)-HIV-coinfected patients prior to and after initiating HAART: role of HCV genotypes.
AIDS research and human retroviruses - 1 Feb 2006
Maida Ivana, Babudieri Sergio, Selva Cinzia, D'Offizi Gianpiero, Fenu Luisa, Solinas Giuliana, Narciso Pasqualino, Mura Maria Stella, Núñez Marina
Abstract excerpt
Transaminase elevation is frequently seen in hepatitis C virus (HCV)-HIV-coinfected patients receiving antiretroviral therapy (ART), representing an increase in the immune response against HCV and being one of the mechanisms proposed to be involved. There is a report claiming that HCV genotype 3 is an independent risk factor. Our objectives were to assess the incidence of liver toxicity in an HIV-HCV-coinfected...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
